REFRACTORY IMMUNE CYTOPENIAS

Clinical trials for REFRACTORY IMMUNE CYTOPENIAS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY IMMUNE CYTOPENIAS trials appear

Sign up with your email to follow new studies for REFRACTORY IMMUNE CYTOPENIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for transplant patients battling stubborn blood cell problems

Disease control Recruiting now

This study is testing whether the drug isatuximab can help adults who develop severe, treatment-resistant low blood counts after a stem cell transplant for blood cancer. The goal is to see if the drug can effectively restore healthy blood cell levels in these patients. It is for …

Matched conditions: REFRACTORY IMMUNE CYTOPENIAS

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

REFRACTORY IMMUNE CYTOPENIAS

Get alerted when new REFRACTORY IMMUNE CYTOPENIAS trials appear

New hope for transplant patients battling stubborn blood cell problems